Insider · CIK 0001368190

Mills Roger

Reports to the SEC for 2 companies · GENEVA

sec.gov

Transactions

Companies

Filings

CIK

0001368190

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	ADXNAddex Therapeutics Ltd.D Disposition to Issuer	Director, CHIEF MEDICAL OFFICER	DDisposition to Issuer	−393K sh	—	—	393,139
2026-09-02	ADXNAddex Therapeutics Ltd.A Award	Director, CHIEF MEDICAL OFFICER	AAward	+393K sh	—	—	785,976
2026-09-02	ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)D Disposition to Issuer	Director, CHIEF MEDICAL OFFICER	DDisposition to Issuer	−50K sh	—	—	0
2026-09-02	ADXNAddex Therapeutics Ltd. · Stock-option (Right to Buy)A Award	Director, CHIEF MEDICAL OFFICER	AAward	+50K sh	—	—	50,000
2015-03-20	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+180K sh	—	—	180,000
2014-11-26	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, DEVELOPMENT AND CMO	MExercise/Conversion	+25K sh	—	—	43,550
2014-11-26	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, DEVELOPMENT AND CMO	SSale	−25K sh	$30.09	−$752K	18,550
2014-11-26	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	EVP, DEVELOPMENT AND CMO	MExercise/Conversion	−25K sh	—	—	139,035
2014-03-07	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+155K sh	—	—	155,000
2013-09-20	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, DEVELOPMENT AND CMO	MExercise/Conversion	+36K sh	—	—	51,740
2013-09-20	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, DEVELOPMENT AND CMO	SSale	−36K sh	$25.01	−$899K	15,775
2013-09-20	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	EVP, DEVELOPMENT AND CMO	MExercise/Conversion	−36K sh	—	—	164,035
2013-06-07	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+175K sh	—	—	175,000
2013-04-01	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, DEVELOPMENT AND CMO	SSale	−58.6K sh	$7.69	−$450K	14,017
2012-03-23	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+175K sh	—	—	175,000
2012-03-23	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+175K sh	—	—	175,000
2011-03-25	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+175K sh	—	—	175,000
2010-03-12	ACADACADIA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+200K sh	—	—	200,000
2006-06-30	ACADACADIA PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	EVP, DEVELOPMENT AND CMO	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Sep 44
Mills Roger0001104659-26-105496
SEC(opens sec.gov)
Mar 244
ACADIA PHARMACEUTICALS INC0001415889-15-001020
SEC(opens sec.gov)
Nov 264
ACADIA PHARMACEUTICALS INC0001415889-14-003736
SEC(opens sec.gov)
Mar 114
ACADIA PHARMACEUTICALS INC0001415889-14-000786
SEC(opens sec.gov)
Sep 204
ACADIA PHARMACEUTICALS INC0001415889-13-001869
SEC(opens sec.gov)
Jun 114
ACADIA PHARMACEUTICALS INC0001415889-13-001165
SEC(opens sec.gov)
Apr 34
Mills Roger0001415889-13-000635
SEC(opens sec.gov)
Mar 264
Mills Roger0001415889-12-000425
SEC(opens sec.gov)
Mar 264/A
Mills Roger0001415889-12-000433
SEC(opens sec.gov)
Mar 294
Mills Roger0001181431-11-020612
SEC(opens sec.gov)
Mar 164
Mills Roger0001181431-10-016676
SEC(opens sec.gov)
Jun 304
Mills Roger0001181431-06-039287
SEC(opens sec.gov)

Companies

Address

CHEMIN DES MINES 9

GENEVA, CH-1202